How to Develop Strong Evidence to Enable Optimal Access Recording

Home / Intelligence / Webinars / How to Develop Strong Evidence to Enable Optimal Access Recording

Available On Demand

Communicating a compelling value story to clinicians and payers is key to launching a product successfully and optimizing value throughout the product lifecycle.

  • But how exactly does one generate evidence that will educate stakeholders on the disease state, shape the future market and support your value narrative?
  • What are the ‘nuts and bolts’ of designing and conducting such studies?
  • How do you distill down to the key value messages from a complex data set to be most impactful to clinical and payer audiences?

Learn how Burden of Illness studies are conducted and how this study type could support your disease areas! The Trinity team will highlight the importance of evidence generation through the lens of a scientific Burden of Illness study that we recently conducted with a global pharma company. Beyond the scientific implications of studies of this kind, we will delve into the real-world applications of this evidence from a market access perspective.

Please complete the form to watch our Trinity Webinar: How to Develop Strong Evidence to Enable Optimal Access.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

Related Intelligence

Webinars

Innovation in Value Strategy: Disrupting the Value Communication Landscape

September 25, 2024 | 12:00 – 12:45 PM ET

Two additional sessions will be offered: September 26 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai September 26 – 15:00 – 15:45 CET – Europe/Berlin  Working at the cutting edge of pricing and market access for innovative therapies launched over the last decade, Trinity Life Sciences has seen new diseases, technologies and decision drivers emerge. These have […]

 Sign Up Now

White Papers

Solving a Pervasive Challenge: Breaking Down Silos in Life Sciences

Experts at Trinity Life Sciences interact with the inner workings of pharma from many perspectives as they engage with teams across life sciences organizations. A common observation is that teams are working in silos: often unaware of what other teams are doing, sometimes pulling in different directions and frequently experiencing frustrations. Internally, siloed working can […]

 Read More

Webinars

Policy Change Through Another Lens: Impact on Health Plans and Implications for Biopharma

September 12, 2024 | 12:00 – 12:45 PM ET

The second webinar in our “Next Era in U.S. Healthcare Policy & Access” series looks at the evolving healthcare policy landscape from a different perspective. Join us as we explore how U.S. policy changes are impacting health plans, how health plan decision-making needs to adapt, and what this means for biopharma companies. The webinar will […]

 Sign Up Now